Bayer, Merial Hit With $32B Class Suit Over Flea Meds

Law360, New York (October 12, 2011, 8:51 PM EDT) -- A dog owner in New York filed a $32 billion putative class action Wednesday alleging Bayer HealthCare LLC and Merial Ltd. regularly make false and deceptive claims in advertisements for their Advantix and Frontline flea and tick pet products.

Mark Bloom, who says he has purchased Merial's Frontline for the past decade, claims that the companies lied about the effectiveness of the products. The insecticides are not self-dispersing over a pet's body, they do enter the bloodstream and are not waterproof, he said.

"Through its sales,...
To view the full article, register now.